NCT06202599Completed
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance:A Multicenter Retrospective Study
Source: ClinicalTrials.gov · Last updated 17 Jan 2024
Brief summary (registry, in English)
This multicenter retrospective study assessed the efficacy and safety of fruquintinib-based treatment in patients with refractory bone and soft tissue sarcomas after several lines of TKIs' resistance.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 124 (actual)
- First submitted
- 21 Dec 2023
- Start date
- 25 Nov 2021
- Primary completion date
- 29 Aug 2023
- Lead sponsor
- Peking University People's Hospital
- Diseases
- Childhood cancers, Sarcoma
- NCT number
- NCT06202599
What you commit to
- Study type: Observational
- Participants enrolled: 124
- From 25 Nov 2021 to the primary completion date, 29 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Failure to complete regular follow-up after administration.
Other
- Discontinued the fruquintinib-based treatment due to neither progression nor unacceptable toxicity.
Who the study is looking for
- Histologically confirmed bone or soft tissue sarcomas;
- Progressed after several lines of therapy;
- Previously treated with other TKIs before fruquintinib;
- Received fruquintinib-based treatment;
- Measurable lesions according to the Response Evaluation Criteria for Solid Tumors (RECIST) version1.1;
- Eastern Cooperative Oncology Group (ECOG) performance status ≤3
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University People's Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.